Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
78
LFST Quote, Financials, Valuation and Earnings
Last price:
$7.01
Seasonality move
:
5.46%
Day range:
$7.00 - $7.19
52-week range:
$3.74 - $8.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.99x
P/B ratio:
1.83x
Volume:
1.1M
Avg. volume:
2.2M
1-year change:
-4.48%
Market cap:
$2.7B
Revenue:
$1.3B
EPS (TTM):
-$0.02
Analysts' Opinion
-
Consensus RatingLifestance Health Group, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.56, Lifestance Health Group, Inc. has an estimated upside of 21.53% from its current price of $7.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.50 representing 100% downside risk from its current price of $7.04.
Fair Value
-
According to the consensus of 8 analysts, Lifestance Health Group, Inc. has 21.53% upside to fair value with a price target of $8.56 per share.
LFST vs. S&P 500
-
Over the past 5 trading days, Lifestance Health Group, Inc. has overperformed the S&P 500 by 0.95% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Lifestance Health Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lifestance Health Group, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Lifestance Health Group, Inc. reported revenues of $363.8M.
Earnings Growth
-
Lifestance Health Group, Inc. has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Lifestance Health Group, Inc. reported earnings per share of $0.00.
Enterprise value:
3B
EV / Invested capital:
--
Price / LTM sales:
1.99x
EV / EBIT:
355.97x
EV / Revenue:
2.20x
PEG ratio (5yr expected):
--
EV / Free cash flow:
25.20x
Price / Operating cash flow:
22.83x
Enterprise value / EBITDA:
46.68x
Gross Profit (TTM):
$388.3M
Return On Assets:
-0.43%
Net Income Margin (TTM):
-0.67%
Return On Equity:
-0.62%
Return On Invested Capital:
-0.47%
Operating Margin:
2.19%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1B | $1.2B | $1.4B | $312.7M | $363.8M | |
| Gross Profit | $204.4M | $297.8M | $388.3M | $85.3M | $103M | |
| Operating Income | -$201.5M | -$63.4M | $8.5M | $181K | $8M | |
| EBITDA | -$124.4M | $15.1M | $64.4M | $15.3M | $21.5M | |
| Diluted EPS | -$0.51 | -$0.25 | -$0.02 | -$0.02 | $0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $328.3M | $252.6M | $264.3M | $287M | $360.4M | |
| Total Assets | $1.9B | $2B | $2.2B | $2.1B | $2.1B | |
| Current Liabilities | $105.2M | $112.3M | $240.9M | $217.5M | $228.6M | |
| Total Liabilities | $369.9M | $448.2M | $720M | $670.8M | $656.2M | |
| Total Equity | $1.5B | $1.5B | $1.5B | $1.4B | $1.5B | |
| Total Debt | $158.8M | $214.2M | $442.5M | $440.7M | $426.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.2M | $61.7M | $150.9M | $22.7M | $27.3M | |
| Cash From Investing | -$79.2M | -$26.7M | -$31.5M | -$5.1M | -$10.3M | |
| Cash From Financing | $29.3M | $25M | -$18.1M | -$2M | -$2M | |
| Free Cash Flow | -$37.3M | $35.1M | $119.4M | $17.7M | $17M | |
LFST
Sector
Market Cap
$2.7B
$28.1M
Price % of 52-Week High
84.87%
50%
Dividend Yield
0%
0%
Shareholder Yield
0.22%
-1.54%
1-Year Price Total Return
-4.48%
-17.67%
Beta (5-Year)
--
0.503
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.08
200-day SMA
Buy
Level
$5.69
Bollinger Bands (100)
Buy
Level
5.08 - 6.5
Chaikin Money Flow
Buy
Level
18M
20-day SMA
Buy
Level
$6.85
Relative Strength Index (RSI14)
Buy
Level
67.82
ADX Line
Buy
Level
37.8
Williams %R
Neutral
Level
-33.4525
50-day SMA
Buy
Level
$6.24
MACD (12, 26)
Buy
Level
0.24
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
21.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.215)
Buy
CA Score
(Annual)
Level (0.3573)
Buy
Beneish M-Score
(Annual)
Level (-2.8397)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.6356)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.
Stock Forecast FAQ
In the current month, LFST has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The LFST average analyst price target in the past 3 months is $8.56.
-
Where Will Lifestance Health Group, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lifestance Health Group, Inc. share price will rise to $8.56 per share over the next 12 months.
-
What Do Analysts Say About Lifestance Health Group, Inc.?
Analysts are divided on their view about Lifestance Health Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lifestance Health Group, Inc. is a Sell and believe this share price will drop from its current level to $6.50.
-
What Is Lifestance Health Group, Inc.'s Price Target?
The price target for Lifestance Health Group, Inc. over the next 1-year time period is forecast to be $8.56 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is LFST A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lifestance Health Group, Inc. is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LFST?
You can purchase shares of Lifestance Health Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lifestance Health Group, Inc. shares.
-
What Is The Lifestance Health Group, Inc. Share Price Today?
Lifestance Health Group, Inc. was last trading at $7.01 per share. This represents the most recent stock quote for Lifestance Health Group, Inc.. Yesterday, Lifestance Health Group, Inc. closed at $7.04 per share.
-
How To Buy Lifestance Health Group, Inc. Stock Online?
In order to purchase Lifestance Health Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LFST Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LFST
Sector
P/E ratio
--
23.88x
PEG ratio
--
-0.01x
P/B ratio
1.83x
1.82x
Price / LTM sales
1.99x
1.59x
Growth Metrics
LFST
Sector
Revenue growth
16.34%
4.73%
Earnings growth
117.83%
11.11%
Revenue (5-year growth)
42.55%
6.46%
Earnings forecast
$0.05
-$0.18
Profitability
LFST
Sector
Profitability FY 2024
$331.4M
$3.6M
Return on invested capital
-0.47%
-31.77%
Return on assets
-0.43%
-28.18%
Return on equity
-0.62%
-37.47%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
LFST
Sector
Total cash
$203.9M
$26.3M
Short term investments
--
$26M
Total assets
$2.2B
$76.9M
Long term debt
$426.3M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 6.72% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 2.43% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 6.14% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
